Refractory Infantyl Chylous Ascites Treatment by Everolimus

Baran M., Kahveci S., AKSOY B., Appak Y. C., Dogan G., Hortu H. O., ...Daha Fazla

MEDENIYET MEDICAL JOURNAL, cilt.40, sa.2, ss.110-113, 2025 (ESCI, Scopus, TRDizin) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 40 Sayı: 2
  • Basım Tarihi: 2025
  • Doi Numarası: 10.4274/mmj.galenos.2025.82284
  • Dergi Adı: MEDENIYET MEDICAL JOURNAL
  • Derginin Tarandığı İndeksler: Emerging Sources Citation Index (ESCI), Scopus, TR DİZİN (ULAKBİM)
  • Sayfa Sayıları: ss.110-113
  • Anahtar Kelimeler: Infantile chylous ascites, everolimus, medical treatment
  • Dokuz Eylül Üniversitesi Adresli: Hayır

Özet

The accumulation of lymphatic fluid in the abdomen is defined as chylous ascites. Different causes play a role in the etiology of the disease. Congenital anomalies are the most common cause in pediatric patients. A high protein, low fat diet rich in medium-chain fatty acids should be planned. The first-line treatment is dietary management and is total parenteral nutrition, and the first preferred medical agent is somatostatin. In patients who do not respond to standard treatments, surgical treatment or new limited alternative medical agents are applied. A six-month-old girl presented with a complaint of abdominal swelling was diagnosed with chylous acid. The patient was put on the standard nutritional therapy and somatostatin treatment but did not respond to these treatments. The chylous ascites was controlled with everolimus treatment.